China Healthcare Weekly (Nov.6)
This article summarized the new healthcare policy released in China, major industry viewpoints, company news and capital markets review for the...
207 Views
Jiangsu Hengrui Medicine (600276 CH) - Q3 Performance Improved with Promising Innovative Pipeline
This article analyzed Hengrui's Q3 performance, strengths in innovation, promotion and internationalization, as well as its forecast and rating.
318 Views
China Healthcare Weekly (Oct.23)
This article summarized important new China healthcare policy released last week, major industry viewpoints, company news and market review for...
249 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
451 Views
SH/SZ Connect Flow Weekly: East Money, BOE, Hengrui, Goertek
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...
210 Views